Abstract
Oncology nursing is concerned with pain relief and overall Quality of Life (QOL). The purpose of this study was to determine the effects of controlled-release morphine on QOL for patients with cancer. Eighty-three subjects were randomly assigned in a clinical trial of short-acting versus controlled-release analgesia (MS Contin, Purdue Frederick Co., Norwalk, CT). Data was collected in a repeated measures design every 2 weeks for 6 weeks yielding a total of 240 visits. Five instruments were used to assess QOL, pain, and functional status. Study findings indicate improved pain management with controlled-release MS Contin and important nursing implications for the management of analgesia-induced gastrointestinal symptoms. Through appropriate pain management with pain therapies such as controlled-release analgesia, nurses can greatly enhance QOL for the patient with cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 521-526 |
| Number of pages | 6 |
| Journal | Oncology nursing forum |
| Volume | 16 |
| Issue number | 4 |
| State | Published - Jul 1989 |
| Externally published | Yes |
ASJC Scopus subject areas
- Oncology(nursing)
Fingerprint
Dive into the research topics of 'Effects of controlled-released morphine on quality of life for cancer pain.'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS